NYSE:PRGO Perrigo (PRGO) Stock Price, News & Analysis $15.95 -0.22 (-1.38%) Closing price 10/21/2026 03:59 PM EasternExtended Trading$15.96 +0.01 (+0.08%) As of 05:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Perrigo Stock (NYSE:PRGO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Perrigo alerts:Sign Up Key Stats Today's Range$15.58▼$16.1350-Day Range$12.82▼$16.5852-Week Range$9.23▼$22.02Volume2.36 million shsAverage Volume2.90 million shsMarket Capitalization$2.21 billionP/E RatioN/ADividend Yield7.27%Price Target$19.33Consensus RatingHold Company Overview Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products. Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels. Its consumer brands have included Compeed, Mederma, ACO, ellaOne and other regional products, while the company also manufactures store-brand alternatives to widely used over-the-counter medicines and personal care products. Founded in 1887, Perrigo has expanded from its origins as a manufacturer of store-brand medicines in the United States into an international consumer healthcare business. The company is incorporated in Ireland and serves consumers primarily across North America and Europe, as well as selected markets in other regions. Patrick Lockwood-Taylor has served as Perrigo’s president and chief executive officer since 2023.AI Generated. May Contain Errors. Read More Perrigo Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScorePRGO MarketRank™: 3.06936647955 of 5 starsPerrigo scored higher than 61% of companies evaluated by MarketBeat, and ranked 337th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingHold Consensus RatingPerrigo has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 4 hold ratings, and 1 sell rating.Upside PotentialPerrigo has a consensus price target of $19.33, representing about 21.2% upside from its current price of $15.95.Amount of Analyst CoveragePerrigo has only been the subject of 1 research reports in the past 90 days.Read more about Perrigo's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth8.26% Earnings GrowthEarnings for Perrigo are expected to grow by 8.26% in the coming year, from $2.18 to $2.36 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Perrigo is -1.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Perrigo is -1.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioPerrigo has a PEG Ratio of 1.85. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPerrigo has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Perrigo's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted17.54% of the float of Perrigo has been sold short.Short Interest Ratio / Days to CoverPerrigo has a short interest ratio ("days to cover") of 7.25.Change versus previous monthShort interest in Perrigo has recently increased by 7.07%, indicating that investor sentiment is decreasing significantly. Dividend4.2 / 5Dividend StrengthStrong Dividend LeadershipPerrigo is a leading dividend payer. It pays a dividend yield of 7.17%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthPerrigo has been increasing its dividend for 23 years.Dividend SustainabilityBased on earnings estimates, Perrigo will have a dividend payout ratio of 49.15% next year. This indicates that Perrigo will be able to sustain or increase its dividend.Read more about Perrigo's dividend. News and Social Media1.4 / 5News Sentiment0.20 News SentimentPerrigo has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Perrigo this week, compared to 8 articles on an average week.Search InterestOnly 4 people have searched for PRGO on MarketBeat in the last 30 days. This is a decrease of -78% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Perrigo to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Perrigo insiders have not sold or bought any company stock.Percentage Held by Insiders0.40% of the stock of Perrigo is held by insiders.Percentage Held by Institutions95.91% of the stock of Perrigo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Perrigo's insider trading history. Receive PRGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRGO Stock News HeadlinesPerrigo to Release Third Quarter 2026 Financial Results on November 4, 2026October 21 at 8:30 AM | prnewswire.comPerrigo (NYSE:PRGO) & Eyepoint Pharmaceuticals (NASDAQ:EYPT) Head to Head AnalysisOctober 19 at 3:45 AM | americanbankingnews.com“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 yearsDr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.October 22 at 1:00 AM | Weiss Ratings (Ad)Perrigo Company plc (PRGO) - What Are Analysts Thinking About This Stock?October 18, 2026 | americanbankingnews.comPerrigo (PRGO) Stock May Be Undervalued Based On Sales TodayOctober 17, 2026 | finance.yahoo.comPerrigo to pay $10 million to settle US class action over baby formula pricesOctober 14, 2026 | reuters.comCritical Contrast: Perrigo (NYSE:PRGO) & Ovid Therapeutics (NASDAQ:OVID)October 13, 2026 | americanbankingnews.comPerrigo: Cheap Valuation Overshadowed By Heavy DebtOctober 13, 2026 | seekingalpha.comSee More Headlines PRGO Stock Analysis - Frequently Asked Questions How have PRGO shares performed this year? Perrigo's stock was trading at $13.92 at the beginning of the year. Since then, PRGO stock has increased by 14.6% and is now trading at $15.9470. How were Perrigo's earnings last quarter? Perrigo Company plc (NYSE:PRGO) issued its quarterly earnings data on Wednesday, August, 5th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.39 by $0.11. The company's revenue for the quarter was down 3.1% on a year-over-year basis. Read the conference call transcript. Does Perrigo have any subsidiaries? The following companies are subsidiaries of Perrigo: HRA Pharma, Ranir, Laboratoire de la Mer SAS, Geiss Destin & Dunn, ScarAway, Omega Pharma, Elan Corporation, and more. Who are Perrigo's major shareholders? Top institutional shareholders of Perrigo include Sound Income Strategies LLC (1.16%), Cooke & Bieler LP (0.75%), O Keefe Stevens Advisory Inc. (0.66%) and Range Financial Group LLC (0.15%). Insiders that own company stock include Svend Andersen, Eduardo Guarita Bezerra, Robert Willis, Ronald Craig Janish, Patrick Lockwood-Taylor, Geoffrey M Parker, Alison Ives, Katherine C Doyle and Abigail Lennox. View institutional ownership trends. How do I buy shares of Perrigo? Shares of PRGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Perrigo own? Based on aggregate information from My MarketBeat watchlists, some other companies that Perrigo investors own include Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Teva Pharmaceutical Industries (TEVA), Pfizer (PFE), Tesla (TSLA), Intel (INTC) and SLB (SLB). Company Calendar Last Earnings8/05/2026Record date for 9/15 Dividend8/28/2026Ex-Dividend for 9/15 Dividend8/28/2026Dividend Payable9/15/2026Today10/22/2026Next Earnings (Estimated)11/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 PRGO's financial health is in the Green zone, according to TradeSmith. PRGO has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:PRGO CIK1585364 Webwww.perrigo.com Phone(531) 709-4000Fax269-673-9128Employees8,100Year Founded1887Price Target and Rating Average Price Target for Perrigo$19.33 High Price Target$23.00 Low Price Target$17.00 Potential Upside/Downside+21.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($12.51) Trailing P/E RatioN/A Forward P/E Ratio7.32 P/E Growth1.85Net Income-$1.43 billion Net Margins-41.85% Pretax Margin-38.90% Return on Equity11.25% Return on Assets4.08% Debt Debt-to-Equity Ratio1.31 Current Ratio2.32 Quick Ratio1.32 Sales & Book Value Annual Sales$4.25 billion Price / Sales0.52 Cash Flow$5.21 per share Price / Cash Flow3.06 Book Value$21.33 per share Price / Book0.75Miscellaneous Outstanding Shares138,770,000Free Float138,214,000Market Cap$2.21 billion OptionableOptionable Beta0.69 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:PRGO) was last updated on 10/21/2026 by MarketBeat.com Staff. From Our PartnersMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | Sponsored80 Days Until the Pentagon Restricts Chinese Rare EarthsChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perrigo Company plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Perrigo With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
